April 18th 2024
A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference assesses the link between antibiotic use and C difficile infection in Tennessee.
Fidaxomicin Versus Vancomycin for Clostridioides Difficile Treatment
April 15th 2022Concomitant antibiotic (CA) use for infection treatment is a major risk factor for recurrent C difficile infection. One SHEA 2022 study examined whether fidaxomicin or vancomycin would be more beneficial for CA patients.
Read More
Ferring’s Microbiome Health Index Measures Gut Microbiota After Antibiotics
January 7th 2022Ferring’s Microbiome Health Index is a diagnostic tool that may help distinguish a healthy gut microbiome from post-antibiotic dysbiosis, and could potentially identify debilitating illnesses such as C difficile infection
Read More
Taking Care of Each Other: The Peggy Lillis Foundation for C Diff Education and Advocacy
December 14th 2021Christian Lillis, co-founder and executive director of the Peggy Lillis Foundation (PLF) for C diff Education & Advocacy, says that taking care of each other is often the best way to stop the spread of infectious diseases.
Watch
Who Is at Risk for Developing Clostridioides Difficile Infection?
An overview of the risk factors that contribute to the development of Clostridioides difficile infection in various health care settings.
Watch
Identifying CDI: Presentation, Prevalence, and Spectrum of Disease
Comprehensive discussion on the identification of Clostridioides difficile infection, the spectrum of disease, and overall epidemiology.
Watch